Cargando…
Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly
Elderly patients (age ≥65 years) with hypertension are at high risk for vascular complications, especially when diabetes is present. Antihypertensive drugs that inhibit the renin-angiotensin system have been shown to be effective for controlling blood pressure in adult and elderly patients. Importan...
Autor principal: | Jugdutt, Bodh I |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998248/ https://www.ncbi.nlm.nih.gov/pubmed/21152242 http://dx.doi.org/10.2147/CIA.S6709 |
Ejemplares similares
-
Valsartan in the Treatment of Heart Attack Survivors
por: Jugdutt, Bodh I
Publicado: (2006) -
Critical appraisal and pooled analysis of telmisartan alone or in combination with hydrochlorothiazide for achieving blood pressure goals
por: Morimoto, Satoshi, et al.
Publicado: (2010) -
Impact of telmisartan in modifying vascular risk
por: Baguet, Jean-Philippe, et al.
Publicado: (2010) -
Experimental Heart Failure Models and Their Pathophysiological Characterization
por: Becher, Peter Moritz, et al.
Publicado: (2016) -
Effect of a fixed-dose combination of Telmisartan/S-amlodipine on circadian blood pressure compared with Telmisartan monotherapy: TENUVA-BP study
por: Kim, Bong-Joon, et al.
Publicado: (2022)